Google-backed Isomorphic Labs raises $2.1B for AI drug discovery platform
Posted:
Isomorphic Labs, an AI drug discovery and development company, raised $2.1 billion in a Series B funding round led by Thrive Capital.
The raise was also backed by existing investors Alphabet and GV (Google Ventures) and new investors MGX, Temasek, CapitalG and the UK Sovereign AI Fund.
GIANT Health is delighted to welcome CareLoop to GIANT Health 2026 as part of the NHS Innovation Accelerator (NIA) Pavilion, where the team will demonstrate how remote monitoring is helping people living with severe mental illness remain well in their…
GIANT Health is delighted to welcome RealBirth to GIANT Health 2026, where the team will showcase how digital innovation is helping transform antenatal education and support more equitable maternity care across the NHS.
Access to high-quality antenatal education plays a…